Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Statistics

Total Valuation

LRMR has a market cap or net worth of $345.36 million. The enterprise value is $197.32 million.

Market Cap	345.36M
Enterprise Value	197.32M

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025, before market open.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

LRMR has 85.59 million shares outstanding. The number of shares has increased by 24.61% in one year.

Current Share Class	85.59M
Shares Outstanding	85.59M
Shares Change (YoY)	+24.61%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	1.02%
Owned by Institutions (%)	35.45%
Float	43.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.07
P/TBV Ratio	2.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.46, with a Debt / Equity ratio of 0.04.

Current Ratio	5.46
Quick Ratio	5.23
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -60.25% and return on invested capital (ROIC) is -39.73%.

Return on Equity (ROE)	-60.25%
Return on Assets (ROA)	-35.04%
Return on Invested Capital (ROIC)	-39.73%
Return on Capital Employed (ROCE)	-88.00%
Revenue Per Employee	n/a
Profits Per Employee	-$1.54M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -49.16% in the last 52 weeks. The beta is 0.92, so LRMR's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-49.16%
50-Day Moving Average	3.56
200-Day Moving Average	3.37
Relative Strength Index (RSI)	55.87
Average Volume (20 Days)	1,364,767

Short Selling Information

The latest short interest is 5.89 million, so 6.89% of the outstanding shares have been sold short.

Short Interest	5.89M
Short Previous Month	6.37M
Short % of Shares Out	6.89%
Short % of Float	13.66%
Short Ratio (days to cover)	3.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-108.54M
Pretax Income	-58.34M
Net Income	-99.79M
EBITDA	-108.21M
EBIT	-108.54M
Earnings Per Share (EPS)	-$1.56

Balance Sheet

The company has $138.52 million in cash and $4.61 million in debt, giving a net cash position of $133.91 million or $1.56 per share.

Cash & Cash Equivalents	138.52M
Total Debt	4.61M
Net Cash	133.91M
Net Cash Per Share	$1.56
Equity (Book Value)	119.85M
Book Value Per Share	1.87
Working Capital	118.91M

Cash Flow

In the last 12 months, operating cash flow was -$92.28 million and capital expenditures -$309,000, giving a free cash flow of -$92.59 million.

Operating Cash Flow	-92.28M
Capital Expenditures	-309,000
Free Cash Flow	-92.59M
FCF Per Share	-$1.08

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LRMR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.61%
Shareholder Yield	-24.61%
Earnings Yield	-30.13%
FCF Yield	-27.95%

Analyst Forecast

The average price target for LRMR is $17.88, which is 343.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.88
Price Target Difference	343.12%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.92%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1